Company intelligence / Profile preview

Eir Ventures

Stockholm, Stockholm, Swedeneirventures.eu ↗

Ownership: Private
Development stage: Other

Overview

Eir Ventures is an active Nordic-focused life science venture capital firm investing in early and mature opportunities addressing significant unmet medical needs. Since its 2020 launch, it has invested in at least 20 companies with 10 clinical programs and two registered products among its portfolio. Five of its investments have reached clinical testing, and two have been listed on NASDAQ US.

Industry: Investors

Partnerships

Novo HoldingsSaminvestEuropean Investment Fund (EIF)Vækstfonden/Danish Growth FundLund UniversityUniversity of Copenhagen

Beyond the preview

Go deeper on Eir Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eir Ventures.

Explore the full profile